Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-05

Clinical Trial Update: Confirmatory Study of OPC-12759 Ophthalmic Solution [Phase 3]

View source ↗

Summary

A Phase 3 confirmatory study of OPC-12759 ophthalmic solution for dry eye has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPC-12759 (OPC-12759)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Dry Eye | Phase 3 | Status: COMPLETED | Results posted: 2021-05-05